(Total Views: 535)
Posted On: 08/12/2019 10:51:13 AM
Post# of 154886
For sure , both Maraviroc and Ibalizumab very low efficacy , 45% and 43 % and some side effects.
I am just very surprise that many posters don't give enough attention to those numbers and side effects ..
To me , globally I don't consider any drug as a serious competition to our Leronlimab for drug resistant HIV at this time .
.
And there are many patients with resistance , globally , in many countries much higher % than in USA..
IMO.
I am just very surprise that many posters don't give enough attention to those numbers and side effects ..
To me , globally I don't consider any drug as a serious competition to our Leronlimab for drug resistant HIV at this time .
.
And there are many patients with resistance , globally , in many countries much higher % than in USA..
IMO.
(1)
(0)
